Elevance Health/$ELV
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Elevance Health
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
Ticker
$ELV
Sector
Primary listing
NYSE
Employees
96,615
Headquarters
Website
Elevance Health Metrics
BasicAdvanced
$87bn
16.97
$23.52
0.67
$6.85
1.72%
Price and volume
Market cap
$87bn
Beta
0.67
52-week high
$426.98
52-week low
$273.71
Average daily volume
1.7m
Dividend rate
$6.85
Financial strength
Current ratio
1.479
Quick ratio
1.332
Long term debt to equity
69.861
Total debt to equity
72.299
Dividend payout ratio (TTM)
28.97%
Interest coverage (TTM)
5.46%
Profitability
EBITDA (TTM)
8,456
Gross margin (TTM)
25.89%
Net profit margin (TTM)
2.62%
Operating margin (TTM)
3.86%
Effective tax rate (TTM)
15.76%
Revenue per employee (TTM)
$2,070,000
Management effectiveness
Return on assets (TTM)
3.98%
Return on equity (TTM)
12.09%
Valuation
Price to earnings (TTM)
16.974
Price to revenue (TTM)
0.443
Price to book
1.98
Price to tangible book (TTM)
19.42
Price to free cash flow (TTM)
13.749
Free cash flow yield (TTM)
7.27%
Free cash flow per share (TTM)
29.034
Dividend yield (TTM)
1.72%
Forward dividend yield
1.72%
Growth
Revenue change (TTM)
9.44%
Earnings per share change (TTM)
-8.15%
3-year revenue growth (CAGR)
7.64%
10-year revenue growth (CAGR)
9.56%
3-year earnings per share growth (CAGR)
-2.31%
10-year earnings per share growth (CAGR)
10.22%
3-year dividend per share growth (CAGR)
8.79%
10-year dividend per share growth (CAGR)
10.50%
What the Analysts think about Elevance Health
Analyst ratings (Buy, Hold, Sell) for Elevance Health stock.
Elevance Health Financial Performance
Revenues and expenses
Elevance Health Earnings Performance
Company profitability
Elevance Health News
AllArticlesVideos
Elevance Health Expands Access to Digital Tools, Helping Bridge the Healthcare Digital Divide
Business Wire·2 weeks ago
Major health insurers show signs of recovery – but a key test looms
CNBC·1 month ago
Elevance Health Advances Efforts to Close Critical Gaps in Mental Health Care
Business Wire·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
FAQs